Outcome Analysis of the Oxford Partial Knee Arthroplasty

This study has been completed.

First Received on September 24, 2008. Last Updated on June 18, 2009 History of Changes

Sponsor:	Biomet, Inc.
Collaborator:	Dartmouth General Hospital
Information provided by:	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00759616

Purpose

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Condition	Intervention
Knee Arthroplasty	Device: Oxford Partial Knee

Study Type:	Interventional
Study Design:	Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Outcome Analysis of the Oxford Partial Knee Arthroplasty

Resource links provided by NLM:

MedlinePlus related topics: Knee Replacement

U.S. FDA Resources

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:

WOMAC, SF12, oxford Knee,KSCRS [ Time Frame: 3weeks, 3months,6months, yearly ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Length of Hospital Stay [ Time Frame: Postop ] [ Designated as safety issue: No ]

Enrollment:	156
Study Start Date:	April 2003
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: 1	Device: Oxford Partial Knee Oxford Partial Knee

Detailed Description:

Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patient Suitable for Knee Replacement

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00759616

Locations

Canada
Dartmouth General Hospital
Dartmouth, Canada

Sponsors and Collaborators

Biomet, Inc.

Dartmouth General Hospital

More Information

No publications provided

Responsible Party:	James Wilson, Biomet Canada
ClinicalTrials.gov Identifier:	NCT00759616 History of Changes
Other Study ID Numbers:	BMET CA 03
Study First Received:	September 24, 2008
Last Updated:	June 18, 2009
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Biomet, Inc.:

Knee Replacement

ClinicalTrials.gov processed this record on February 09, 2012